Amid the market’s wild roller coaster ride, one fact has become abundantly clear: COVID-19 is a game-changer. With the number of new cases spiking, the resumption of normality is fading
Amid the market’s wild roller coaster ride, one fact has become abundantly clear: COVID-19 is a game-changer. With the number of new cases spiking, the resumption of normality is fading
No pain, no gain goes the well-worn axiom. A stock market themed inverse can read: no gain, shareholder pain. You can currently apply the latter to Intercept Pharmaceuticals (ICPT). The
Farewell 2Q20 – the best quarter for stocks since 1998. While everyone has been trying to make sense of the almost absurd market gains, the facts cannot be denied. One
As we enter the second half of the year, pharma companies are still frantically engaged in the search for a COVID-19 vaccine. There are many companies in the mix, but
The coronavirus marches on, but healthcare names all over the world are fighting back. Earlier this week, Gilead Sciences (GILD), the manufacturer of COVID-19 antiviral drug remdesivir, revealed the pricing